Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127373531 | 12737353 | 1 | I | 20160503 | 20160913 | 20160913 | EXP | US-ASTELLAS-2016US017300 | ASTELLAS | 0.00 | M | Y | 0.00000 | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127373531 | 12737353 | 1 | PS | XTANDI | ENZALUTAMIDE | 1 | Oral | 203415 | 160 | MG | CAPSULE | QD | |||||||
| 127373531 | 12737353 | 2 | SS | LUPRON | LEUPROLIDE ACETATE | 1 | Unknown | UNK, UNKNOWN FREQ. | U | 0 | INJECTION | ||||||||
| 127373531 | 12737353 | 3 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 127373531 | 12737353 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 127373531 | 12737353 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 127373531 | 12737353 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 127373531 | 12737353 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 127373531 | 12737353 | 8 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127373531 | 12737353 | 1 | Prostate cancer |
| 127373531 | 12737353 | 2 | Product used for unknown indication |
| 127373531 | 12737353 | 3 | Product used for unknown indication |
| 127373531 | 12737353 | 4 | Product used for unknown indication |
| 127373531 | 12737353 | 5 | Product used for unknown indication |
| 127373531 | 12737353 | 6 | Product used for unknown indication |
| 127373531 | 12737353 | 7 | Product used for unknown indication |
| 127373531 | 12737353 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127373531 | 12737353 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127373531 | 12737353 | Diarrhoea | |
| 127373531 | 12737353 | Fatigue | |
| 127373531 | 12737353 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127373531 | 12737353 | 1 | 20160414 | 0 |